BANK1 regulates IgG production in a lupus model by controlling TLR7-dependent STAT1 activation

PLoS ONE

Volumn 11, Issue 5, 2016, Pages

  Wu, Ying Yu ^a   Kumar, Ramesh ^a   Iida, Ryuji ^a,c   Bagavant, Harini ^a   Alarcón Riquelme, Marta E ^a,b  

^a OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^b UNIVERSITY OF GRANADA   (Spain)

^c NATIONAL INSTITUTE OF BIOMEDICAL INNOVATION   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; B CELL ACTIVATING FACTOR; CHEMOKINE RECEPTOR CXCR4; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 6; SERINE; STAT1 PROTEIN; TOLL LIKE RECEPTOR 7; TYROSINE; BANK1 PROTEIN, MOUSE; MEMBRANE PROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; STAT1 PROTEIN, MOUSE; TLR7 PROTEIN, MOUSE;

AICDA GENE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; BANK1 GENE; BONE MARROW CELL; CELL COUNT; CONTROLLED STUDY; GENE; GENE CONTROL; GENE EXPRESSION; GENE FUNCTION; GENE TRANSLOCATION; GENETIC TRANSCRIPTION; GERMINAL CENTER; HELPER CELL; IFNA4 GENE; IFNB GENE; IMMUNOGLOBULIN PRODUCTION; IN VITRO STUDY; IRF7 GENE; MOUSE; NONHUMAN; PATHOGENESIS; PHENOTYPE; PLASMA CELL; SIGNAL TRANSDUCTION; STAT1 GENE; SYSTEMIC LUPUS ERYTHEMATOSUS; TLR7 GENE; ANIMAL; BLOOD; C57BL MOUSE; CELL CULTURE; FEMALE; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; MALE; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; AUTOANTIBODIES; B-LYMPHOCYTES; CELLS, CULTURED; FEMALE; IMMUNOGLOBULIN G; INTERLEUKIN-6; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PHENOTYPE; STAT1 TRANSCRIPTION FACTOR; TOLL-LIKE RECEPTOR 7;

EID: 84971373690     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0156302     Document Type: Article

References (44)

1. Yokoyama K, Su Ih IH, Tezuka T, Yasuda T, Mikoshiba K, Tarakhovsky A et al. BANK regulates BCR-induced calcium mobilization by promoting tyrosine phosphorylation of IP(3) receptor. Embo J, 2002; 21:83-92. PMID: 11782428
2. Aiba Y, Yamazaki T, Okada T, Gotoh K, Sanjo H, Ogata M et al. BANK negatively regulates Akt activation and subsequent B cell responses. Immunity, 2006; 24:259-68. PMID: 16546095
3. Bernal-Quiros M, Wu YY, Alarcon-Riquelme ME, Castillejo-Lopez C. BANK1 and BLK Act through Phospholipase C Gamma 2 in B-Cell Signaling. PLoS ONE, 2013; 8:e59842. doi: 10.1371/journal.pone.0059842 PMID: 23555801
4. Troutman TD, Hu W, Fulenchek S, Yamazaki T, Kurosaki T, Bazan JF et al. Role for B-cell adapter for PI3K (BCAP) as a signaling adapter linking Toll-like receptors (TLRs) to serine/threonine kinases PI3K/Akt. Proceedings of the National Academy of Sciences of the United States of America, 2012; 109:273-8. doi: 10.1073/pnas.1118579109 PMID: 22187460
5. Wu YY, Kumar R, Haque MS, Castillejo-Lopez C, Alarcon-Riquelme ME. BANK1 Controls CpG-Induced IL-6 Secretion via a p38 and MNK1/2/eIF4E Translation Initiation Pathway. Journal of immunology, 2013; 191:6110-6.
6. Kozyrev SV, Abelson AK, Wojcik J, Zaghlool A, Linga Reddy MV, Sanchez E et al. Functional variants in the B-cell gene BANK1 are associated with systemic lupus erythematosus. Nat Genet, 2008; 40:211-6. doi: 10.1038/ng.79 PMID: 18204447
7. Dieude P, Wipff J, Guedj M, Ruiz B, Melchers I, Hachulla E et al. BANK1 is a genetic risk factor for diffuse cutaneous systemic sclerosis and has additive effects with IRF5 and STAT4. Arthritis Rheum, 2009; 60:3447-54. doi: 10.1002/art.24885 PMID: 19877059
8. Orozco G, Abelson AK, Gonzalez-Gay MA, Balsa A, Pascual-Salcedo D, Garcia A et al. Study of functional variants of the BANK1 gene in rheumatoid arthritis. Arthritis Rheum, 2009; 60:372-9. doi: 10.1002/art.24244 PMID: 19180476
9. Suarez-Gestal M, Calaza M, Dieguez-Gonzalez R, Perez-Pampin E, Pablos JL, Navarro F et al. Rheumatoid arthritis does not share most of the newly identified systemic lupus erythematosus genetic factors. Arthritis and Rheumatism, 2009; 60:2558-64. doi: 10.1002/art.24748 PMID: 19714582
10. Kawai T, Akira S. TLR signaling. Cell Death Differ, 2006; 13:816-25. PMID: 16410796
11. Nickerson KM, Christensen SR, Shupe J, Kashgarian M, Kim D, Elkon K et al. TLR9 regulates TLR7- and MyD88-dependent autoantibody production and disease in a murine model of lupus. J Immunol, 2010; 184:1840-8. doi: 10.4049/jimmunol.0902592 PMID: 20089701
12. Santiago-Raber ML, Dunand-Sauthier I, Wu T, Li QZ, Uematsu S, Akira S et al. Critical role of TLR7 in the acceleration of systemic lupus erythematosus in TLR9-deficient mice. Journal of autoimmunity, 2010; 34:339-48. doi: 10.1016/j.jaut.2009.11.001 PMID: 19944565
13. Berland R, Fernandez L, Kari E, Han JH, Lomakin I, Akira S et al. Toll-like receptor 7-dependent loss of B cell tolerance in pathogenic autoantibody knockin mice. Immunity, 2006; 25:429-40. PMID: 16973388
14. Wu X, Peng SL. Toll-like receptor 9 signaling protects against murine lupus. Arthritis Rheum, 2006; 54:336-42. PMID: 16385525
15. Walsh ER, Pisitkun P, Voynova E, Deane JA, Scott BL, Caspi RR et al. Dual signaling by innate and adaptive immune receptors is required for TLR7-induced B-cell-mediated autoimmunity. Proceedings of the National Academy of Sciences of the United States of America, 2012; 109:16276-81. doi: 10.1073/pnas.1209372109 PMID: 22988104
16. Kiefer K, Oropallo MA, Cancro MP, Marshak-Rothstein A. Role of type I interferons in the activation of autoreactive B cells. Immunol Cell Biol, 2012; 90:498-504. doi: 10.1038/icb.2012.10 PMID: 22430248
17. Green NM, Laws A, Kiefer K, Busconi L, Kim YM, Brinkmann MM et al. Murine B cell response to TLR7 ligands depends on an IFN-beta feedback loop. J Immunol, 2009; 183:1569-76. doi: 10.4049/jimmunol.0803899 PMID: 19587008
18. Villarino AV, Kanno Y, Ferdinand JR, O'Shea JJ. Mechanisms of Jak/STAT signaling in immunity and disease. J Immunol, 2015; 194:21-7. doi: 10.4049/jimmunol.1401867 PMID: 25527793
19. Pan ZJ, Maier S, Schwarz K, Azbill J, Akira S, Uematsu S et al. Toll-like receptor 7 (TLR7) modulates anti-nucleosomal autoantibody isotype and renal complement deposition in mice exposed to syngeneic late apoptotic cells. Annals of the rheumatic diseases, 2010; 69:1195-9. doi: 10.1136/ard.2009.108282 PMID: 19674980
20. Lau CM, Broughton C, Tabor AS, Akira S, Flavell RA, Mamula MJ et al. RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement. J Exp Med, 2005; 202:1171-7. PMID: 16260486
21. Liu Z, Davidson A. IFNalpha Inducible Models of Murine SLE. Front Immunol, 2013; 4:306. doi: 10.3389/fimmu.2013.00306 PMID: 24106491
22. Marshak-Rothstein A, Rifkin IR. Immunologically active autoantigens: the role of toll-like receptors in the development of chronic inflammatory disease. Annu Rev Immunol, 2007; 25:419-41. PMID: 17378763
23. Morel L, Blenman K.R., Croker B.P., Wakeland E.K. The major murine systemic lupus erythematosus susceptibility locus, Sle1, is a cluster of functionally related genes. Proc Natl Acad Sci U S A, 2001; 98:1787-92. PMID: 11172029
24. Subramanian S, Tus K, Li QZ, Wang A, Tian XH, Zhou J et al. A Tlr7 translocation accelerates systemic autoimmunity in murine lupus. Proc Natl Acad Sci U S A, 2006; 103:9970-5. PMID: 16777955
25. Pisitkun P, Deane JA, Difilippantonio MJ, Tarasenko T, Satterthwaite AB, Bolland S. Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication. Science, 2006; 312:1669-72. PMID: 16709748
26. Fairhurst AM, Hwang SH, Wang A, Tian XH, Boudreaux C, Zhou XJ et al. Yaa autoimmune phenotypes are conferred by overexpression of TLR7. European journal of immunology, 2008; 38:1971-8. doi: 10.1002/eji.200838138 PMID: 18521959
27. Deane JA, Pisitkun P, Barrett RS, Feigenbaum L, Town T, Ward JM et al. Control of toll-like receptor 7 expression is essential to restrict autoimmunity and dendritic cell proliferation. Immunity, 2007; 27:801-10. PMID: 17997333
28. Maier-Moore JS, Horton CG, Mathews SA, Confer AW, Lawrence C, Pan Z et al. Interleukin-6 Deficiency Corrects Nephritis, Lymphocyte Abnormalities, and Secondary Sjogren's Syndrome Features in Lupus-Prone Sle1.Yaa Mice. Arthritis Rheumatol, 2014; 66:2521-31. doi: 10.1002/art.38716 PMID: 24891301
29. Davidson A. The rationale for BAFF inhibition in systemic lupus erythematosus. Current rheumatology reports, 2012; 14:295-302. doi: 10.1007/s11926-012-0258-2 PMID: 22535567
30. Stohl W, Xu D, Kim KS, Koss MN, Jorgensen TN, Deocharan B et al. BAFF overexpression and accelerated glomerular disease in mice with an incomplete genetic predisposition to systemic lupus erythematosus. Arthritis Rheum, 2005; 52:2080-91. PMID: 15986357
31. Poholek AC, Hansen K, Hernandez SG, Eto D, Chandele A, Weinstein JS et al. In vivo regulation of Bcl6 and T follicular helper cell development. J Immunol, 2010; 185:313-26. doi: 10.4049/jimmunol.0904023 PMID: 20519643
32. Allman D, Lindsley RC, DeMuth W, Rudd K, Shinton SA, Hardy RR. Resolution of three nonproliferative immature splenic B cell subsets reveals multiple selection points during peripheral B cell maturation. J Immunol, 2001; 167:6834-40. PMID: 11739500
33. Maeda K, Malykhin A, Teague-Weber BN, Sun XH, Farris AD, Coggeshall KM. Interleukin-6 aborts lymphopoiesis and elevates production of myeloid cells in systemic lupus erythematosus-prone B6.Sle1.Yaa animals. Blood, 2009; 113:4534-40.
34. Luu K, Greenhill CJ, Majoros A, Decker T, Jenkins BJ, Mansell A. STAT1 plays a role in TLR signal transduction and inflammatory responses. Immunol Cell Biol, 2014; 92:761-9. doi: 10.1038/icb.2014.51 PMID: 25027037
35. Zhang Z, Goldschmidt T, Salter H. Possible allelic structure of IgG2a and IgG2c in mice. Molecular immunology, 2012; 50:169-71. doi: 10.1016/j.molimm.2011.11.006 PMID: 22177661
36. Joshi S, Kaur S, Redig AJ, Goldsborough K, David K, Ueda T et al. Type I interferon (IFN)-dependent activation of Mnk1 and its role in the generation of growth inhibitory responses. Proc Natl Acad Sci U S A, 2009; 106:12097-102. doi: 10.1073/pnas.0900562106 PMID: 19574459
37. Joshi S, Kaur S, Kroczynska B, Platanias LC. Mechanisms of mRNA translation of interferon stimulated genes. Cytokine, 2010; 52:123-7. doi: 10.1016/j.cyto.2010.03.019 PMID: 20409730
38. Hwang SH, Lee H, Yamamoto M, Jones LA, Dayalan J, Hopkins R et al. B Cell TLR7 Expression Drives Anti-RNA Autoantibody Production and Exacerbates Disease in Systemic Lupus Erythematosus-Prone Mice. Journal of immunology, 2012; 189:5786-96.
39. Thibault DL, Chu AD, Graham KL, Balboni I, Lee LY, Kohlmoos C et al. IRF9 and STAT1 are required for IgG autoantibody production and B cell expression of TLR7 in mice. The Journal of clinical investigation, 2008; 118:1417-26. doi: 10.1172/JCI30065 PMID: 18340381
40. Nguyen HV, Mouly E, Chemin K, Luinaud R, Despres R, Fermand JP et al. The Ets-1 transcription factor is required for Stat1-mediated T-bet expression and IgG2a class switching in mouse B cells. Blood, 2012; 119:4174-81. doi: 10.1182/blood-2011-09-378182 PMID: 22438254
41. Tangye SG. Advances in IL-21 biology - enhancing our understanding of human disease. Curr Opin Immunol, 2015; 34:107-15. doi: 10.1016/j.coi.2015.02.010 PMID: 25801685
42. Wang A, Fairhurst AM, Tus K, Subramanian S, Liu Y, Lin F et al. CXCR4/CXCL12 hyperexpression plays a pivotal role in the pathogenesis of lupus. Journal of immunology, 2009; 182:4448-58.
43. Elsner RA, Ernst DN, Baumgarth N. Single and coexpression of CXCR4 and CXCR5 identifies CD4 T helper cells in distinct lymph node niches during influenza virus infection. J Virol, 2012; 86:7146-57. doi: 10.1128/JVI.06904-11 PMID: 22532671
44. Odegard JM, Marks BR, DiPlacido LD, Poholek AC, Kono DH, Dong C et al. ICOS-dependent extrafollicular helper T cells elicit IgG production via IL-21 in systemic autoimmunity. J Exp Med, 2008; 205:2873-86. doi: 10.1084/jem.20080840 PMID: 18981236